If the H7N9 influenza virus now circulating in China evolves into a pandemic strain, the world is likely to have great difficulty providing adequate supplies of an effective vaccine in time to blunt its impact, according to a viewpoint article by three experts in the Journal of the American Medical Association (JAMA).
(CIDRAP News) – US influenza policy experts who gathered in Washington, DC, today called for better vaccines and other steps for improving pandemic and seasonal flu preparedness, themes echoed in an action plan released by the Infectious Diseases Society of America (IDSA).
(CIDRAP News) North Carolina health officials have reported a number of influenza B isolates with reduced sensitivity to oseltamivir (Tamiflu), a rare finding, but they say antivirals remain effective and there is no reason for clinicians to change their prescribing practices.
(CIDRAP News) A federal vaccine advisory group meeting in Washington, DC, today unveiled a new national vaccination strategy for the next decade and reviewed the latest information on influenza vaccination in the first year of a new universal recommendation.
(CIDRAP News) Six new members have been appointed to the National Biodefense Science Board (NBSB), the expert committee that advises the US Department of Health and Human Services (HHS) on preparing for bioterrroism and other public health emergencies, HHS officials announced yesterday.
The six new members replace six whose 3-year terms ended Dec 31, HHS said in a news release.
(CIDRAP News) A comprehensive review of the nation's tools for reducing the impact of a biological weapons attack or other public health emergencyprompted in part by last fall's delays in delivery of the pandemic H1N1 vaccineis due to get under way in the next few weeks with a pair of conferences.
(CIDRAP News) Today was the 12th year the National Foundation for Infectious Diseases (NFID) has held a press conference to discuss its expectations for the upcoming flu season, but discussions were far from routine, reflecting uncertainty surrounding the pandemic flu strain and the complexity of launching two vaccine campaigns.